BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2021
View Archived Issues
Onxeo partners with Institut Curie to study AsiDNA with radiotherapy in pediatric high-grade glioma
Read More
Morphine itch comes from neurons, not mast cells
Read More
Sinovac's CoronaVac COVID-19 vaccine granted conditional marketing authorization in China
Read More
ORIC Pharmaceuticals presents new CD73 inhibitors
Read More
Canopy Growth synthesizes cannabinoid CB1 and CB2 receptor ligands
Read More
GB005 identifies new BTK inhibitors
Read More
King Abdulaziz University describes DPP-IV inhibitors
Read More
GenScript discloses new anti-CD47/anti-PD-1 bispecific antibodies
Read More
Positive phase II data for VERU-111 in hospitalized COVID-19 patients at high risk for ARDS
Read More
Reduction of NK-activating ligand NKG2DL contributes to immune scape in SCLC and neuroblastoma
Read More
Study identifies a transcriptional feedback loop regulating fatty acid synthesis in EAC
Read More
Rukobia approved in Europe for adults with multidrug-resistant HIV
Read More
Phase Ib data presented for DA-1241 patients with type 2 diabetes
Read More
Phase I trial shows MB-66 to be acceptable and effective in healthy reproductive women
Read More
Ad5-nCoV vaccine meets prespecified primary safety and efficacy criteria for phase III study
Read More
Innovent begins pivotal study of IBI-310 with sintilimab for first-line advanced HCC
Read More
FDA clears Catapult's IND for phase I trial of CAP-100 in CLL
Read More
ImmunoMet Therapeutics set to begin phase I U.S. study of IM-156 in IPF
Read More
AVROBIO reports new advances with upgraded gene therapy platform
Read More
Jasper Therapeutics presents phase I data for anti-CD117 JSP-191 MAb
Read More
Positive interim phase I data presented for COVID-19 vaccine candidate UB-612
Read More
KalVista releases phase II data on KVD-900 as oral on-demand treatment for HAE
Read More
European Commission approves Inrebic for newly diagnosed and previously treated myelofibrosis
Read More
